HSPD1 and prostate carcinoma: Sandeep et al. [40, 46] found that knocking down HSP60 decreased IL-8 expression and its release in prostate cancer cell xenograft tumors in SCID mice, indicating that the HSP60 and IL-8 axis promoted apoptosis resistance in cancer.